INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "4-{4-[(1-{[4-(PROPAN-2-YL)PHENYL]CARBAMOYL)-D-PROLYL)AMINO]CYCLOHEXYL}BENZOIC ACID DERIVATIVES AS GIPR ANTAGONISTS FOR THE TREATMENT OF DIABETES"

GENEVA, March 2 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/058383) for "4-{4-[(1-{[4-(PROPAN-2-YL)PHENYL]CARBAMOYL)-D-PROLYL)AMINO]CYCLOHEXYL}BENZOIC ACID DERIVATIVES AS GIPR ANTAGONISTS FOR THE TREATMENT OF DIABETES" on Aug 19, 2025. With publication no. WO/2026/042018, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FILIPSKI, Kevin James (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139), LEVI, Samuel Michael (c/o Pfizer Inc.10777 Science Cen...